Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Wuhan Wansheng Biotechnology.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 74 | 99.51% | Sep 4, 2026 |
| Tirzepatide | 53 | 99.71% | Sep 3, 2026 |
| Tesamorelin | 27 | 94.35% | Sep 3, 2026 |
| GHK-Cu | 23 | 99.91% | Aug 25, 2026 |
| BPC-157 | 19 | 99.25% | Jun 22, 2026 |
| Ipamorelin | 15 | 99.49% | Sep 3, 2026 |
| Cagrilintide | 14 | 98.57% | May 5, 2026 |
| Melanotan II | 6 | 99.31% | Jun 30, 2026 |
| CJC-1295 No DAC | 5 | 92.66% | Jan 25, 2026 |
| Semaglutide | 5 | 94.88% | Jun 21, 2026 |
| TB-500 | 5 | 96.49% | Mar 24, 2026 |
| PT-141 | 4 | 99.82% | Jan 18, 2026 |
| TB-500 Thymosin Beta-4 | 3 | 94.97% | Jun 22, 2026 |
| CJC-1295 DAC | 2 | 89.94% | Mar 5, 2026 |
| TB-500 Fragment 17-23 | 1 | 99.9% | Mar 5, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Retatrutide | RT15WWB072126 | 99.9% | Lab G | Sep 4, 2026 | verify |
| Tirzepatide | TR10WWB062026 | n/a | Lab E | Sep 3, 2026 | verify |
| Tesamorelin | TSM10 | 99.9% | Lab E | Sep 3, 2026 | verify |
| Ipamorelin | n/a | 98.2% | Lab E | Sep 3, 2026 | verify |
| GHK-Cu | CU50WWB062026 | 99.9% | Lab E | Aug 25, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 25, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 12, 2026 | verify |
| Retatrutide | RT10WWB052626 | 99.9% | Lab E | Aug 12, 2026 | verify |
| Retatrutide | n/a | 99.6% | Lab E | Jul 21, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jul 16, 2026 | verify |
| Ipamorelin | IP101020260220-2 | 98.8% | Lab E | Jul 16, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Jun 30, 2026 | verify |
| Melanotan II | n/a | 99.9% | Lab E | Jun 30, 2026 | verify |
| Tirzepatide | n/a | 99.8% | Lab G | Jun 25, 2026 | verify |
| Tesamorelin | TSM-2605-1 | 99.9% | Lab E | Jun 23, 2026 | verify |
| BPC-157 | n/a | 99.3% | Lab E | Jun 22, 2026 | verify |
| TB-500 Thymosin Beta-4 | 6.4 | 99.7% | Lab E | Jun 22, 2026 | verify |
| Semaglutide | n/a | 99.9% | Lab E | Jun 21, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jun 21, 2026 | verify |
| GHK-Cu | WWB-CU100-26-04 | 99.9% | Lab E | Jun 11, 2026 | verify |
| Retatrutide | R15-2605-1 | 99.7% | Lab G | Jun 11, 2026 | verify |
| Retatrutide | WWB-RET-26-04 | 99.6% | Lab E | Jun 11, 2026 | verify |
| Melanotan II | WWB-ML10-26-04 | 99.9% | Lab E | Jun 11, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab G | May 24, 2026 | verify |
| Retatrutide | n/a | 99.6% | Lab G | May 17, 2026 | verify |
Showing 25 most recent of 256. Search the full database on the CoA page.
Sell or represent Wuhan Wansheng Biotechnology? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/wuhan-wansheng-biotechnology/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/wuhan-wansheng-biotechnology.svg" alt="Wuhan Wansheng Biotechnology: lab tested, 256 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.